Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis total assets
Total assets on the balance sheet at the end of each period.
Enovis's total assets was $3.77B at Jul 3, 2026. For fiscal 2025 it was $3.83B, down 18.7% from the year before. Over ten years it grew -5.5% a year on average. The highest annual figure on record is $8.52B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.83B | -18.7% |
| FY2024 | Dec 31, 2024 | $4.72B | +4.6% |
| FY2023 | Dec 31, 2023 | $4.51B | +5.5% |
| FY2022 | Dec 31, 2022 | $4.27B | -49.8% |
| FY2021 | Dec 31, 2021 | $8.52B | +15.8% |
| FY2020 | Dec 31, 2020 | $7.35B | -0.5% |
| FY2019 | Dec 31, 2019 | $7.39B | +11.7% |
| FY2018 | Dec 31, 2018 | $6.62B | -1.4% |
| FY2017 | Dec 31, 2017 | $6.71B | +5.9% |
| FY2016 | Dec 31, 2016 | $6.34B | -5.9% |
| FY2015 | Dec 31, 2015 | $6.73B | -6.6% |
| FY2014 | Dec 31, 2014 | $7.21B | +9.2% |
| FY2013 | Dec 31, 2013 | $6.60B | +7.4% |
| FY2012 | Dec 31, 2012 | $6.15B | +464.8% |
| FY2011 | Dec 31, 2011 | $1.09B | +6.5% |
| FY2010 | Dec 31, 2010 | $1.02B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $3.77B | -25.0% |
| Q1 FY2026 | Apr 3, 2026 | $3.83B | -21.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.83B | -18.7% |
| Q3 FY2025 | Oct 3, 2025 | $4.43B | -20.1% |
| Q2 FY2025 | Jul 4, 2025 | $5.02B | -7.7% |
| Q1 FY2025 | Apr 4, 2025 | $4.88B | -11.0% |
| Q4 FY2024 | Dec 31, 2024 | $4.72B | +4.6% |
| Q3 FY2024 | Sep 27, 2024 | $5.55B | +26.1% |
| Q2 FY2024 | Jun 28, 2024 | $5.44B | +22.5% |
| Q1 FY2024 | Mar 29, 2024 | $5.48B | +27.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.51B | +5.5% |
| Q3 FY2023 | Sep 29, 2023 | $4.40B | -1.0% |
| Q2 FY2023 | Jun 30, 2023 | $4.44B | -1.3% |
| Q1 FY2023 | Mar 31, 2023 | $4.30B | -49.3% |
| Q4 FY2022 | Dec 31, 2022 | $4.27B | -49.8% |
| Q3 FY2022 | Sep 30, 2022 | $4.44B | -44.2% |
| Q2 FY2022 | Jul 1, 2022 | $4.50B | -40.4% |
| Q1 FY2022 | Apr 1, 2022 | $8.48B | +5.2% |
| Q4 FY2021 | Dec 31, 2021 | $8.52B | +15.8% |
| Q3 FY2021 | Oct 1, 2021 | $7.97B | +11.4% |
| Q2 FY2021 | Jul 2, 2021 | $7.56B | +6.1% |
| Q1 FY2021 | Apr 2, 2021 | $8.07B | +8.2% |
| Q4 FY2020 | Dec 31, 2020 | $7.35B | -0.5% |
| Q3 FY2020 | Oct 2, 2020 | $7.15B | -25.4% |
| Q2 FY2020 | Jul 3, 2020 | $7.12B | -28.0% |
| Q1 FY2020 | Apr 3, 2020 | $7.46B | -29.0% |
| Q4 FY2019 | Dec 31, 2019 | $7.39B | +11.7% |
| Q3 FY2019 | Sep 27, 2019 | $9.59B | +48.8% |
| Q2 FY2019 | Jun 28, 2019 | $9.90B | +53.2% |
| Q1 FY2019 | Mar 29, 2019 | $10.50B | +52.7% |
| Q4 FY2018 | Dec 31, 2018 | $6.62B | -1.4% |
| Q3 FY2018 | Sep 28, 2018 | $6.45B | -5.7% |
| Q2 FY2018 | Jun 29, 2018 | $6.46B | -4.0% |
| Q1 FY2018 | Mar 31, 2018 | $6.88B | +7.0% |
| Q4 FY2017 | Dec 31, 2017 | $6.71B | +5.9% |
| Q3 FY2017 | Sep 29, 2017 | $6.84B | +4.5% |
| Q2 FY2017 | Jun 30, 2017 | $6.73B | – |
| Q1 FY2017 | Mar 31, 2017 | $6.43B | – |
| Q4 FY2016 | Dec 31, 2016 | $6.34B | – |
| Q3 FY2016 | Sep 30, 2016 | $6.54B | – |
See a number that looks wrong?